Improving detection of adverse effects of marketed drugs

JAMA. 2007 Jul 18;298(3):333-4. doi: 10.1001/jama.298.3.333.

Authors

Donald F Klein¹, Charles P O'Brien

Affiliation

¹ University of Pennsylvania, Philadelphia, PA 19104-6178, USA.

PMID: 17635895
DOI: 10.1001/jama.298.3.333

No abstract available

MeSH terms

Adverse Drug Reaction Reporting Systems*
Databases, Factual
Drug-Related Side Effects and Adverse Reactions*
Humans
Pharmacoepidemiology
Population Surveillance
United States
United States Food and Drug Administration